Tanzania - English - Tanzania Medicinces & Medical Devices Authority

shanghai fosun pharmaceutical industrial development co., ltd, china - rivaroxaban - film coated tablets - 20

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

shanghai fosun pharmaceutical industrial development co., ltd, china - sulfadoxine/pyrimethamine/amodiaquine (as hydrochloride) - dispersible tablets - 250/12.5/76.5

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

shanghai fosun pharmaceutical industrial development co., ltd, china - furosemide - solution for injection - 10

United States - English - NLM (National Library of Medicine)

a-s medication solutions - ketorolac tromethamine (unii: 4eve5946bq) (ketorolac - unii:yzi5105v0l) - carefully consider the potential benefits and risks ketorolac tromethamine and other treatment options before deciding to use ketorolac. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). acute pain in adult patients ketorolac tromethamine is indicated for the short-term (≤5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. therapy should always be initiated with intravenous or intramuscular dosing of ketorolac tromethamine and oral ketorolac tromethamine is to be used only as continuation treatment, if necessary. the total combined duration of use of ketorolac tromethamine injection and oral ketorolac tromethamine is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses (see warnings, precautions, dosage and admi

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

shanghai fosun pharmaceutical industrial development co., ltd, china - sulfadoxine/pyrimethamine/amodiaquine (as hydrochloride) - dispersible tablets - 500/25

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fosun pharma sp. z o.o. - voriconazole 200 mg - powder for solution for infusion - voriconazole

United States - English - NLM (National Library of Medicine)

medical purchasing solutions, llc - metoprolol tartrate (unii: w5s57y3a5l) (metoprolol - unii:geb06nhm23) - metoprolol tartrate injection is indicated in the treatment of definite or suspected acute myocardial infarction in hemodynamically stable patients to reduce cardiovascular mortality when used in conjunction with oral metoprolol maintenance therapy. hypersensitivity to metoprolol and related derivatives, or to any of the excipients; hypersensitivity to other beta blockers (cross sensitivity between beta blockers can occur). metoprolol is contraindicated in patients with a heart rate <45 beats/min; second-and third-degree heart block (unless a functioning pacemaker is present); significant first-degree heart block (p-r interval ≥0.24 sec); systolic blood pressure <100 mmhg; or decompensated cardiac failure. risk summary available data from published observational studies have not demonstrated an association of adverse developmental outcomes with maternal use of metoprolol during pregnancy (see data). untreated hypertension and heart failure during pregnancy can lead to adverse ou

United States - English - NLM (National Library of Medicine)

a-s medication solutions - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin ophthalmic solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: corynebacterium species * micrococcus luteus* staphylococcus aureus staphylococcus epidermidis staphylococcus haemolyticus staphylococcus hominis staphylococcus warneri* streptococcus pneumoniae streptococcus viridans group acinetobacter lwoffii* haemophilus influenzae haemophilus parainfluenzae* chlamydia trachomatis *efficacy for this organism was studied in fewer than 10 infections. moxifloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to moxifloxacin, to other quinolones, or to any of the components in this medication. pregnancy c

Uganda - English - National Drug Authority

fosun pharmaceutical distribution jiangsu co. ltd - artemether + lumefantrine - oral solid ordinary soluble tablets - 20mg + 120mg

Uganda - English - National Drug Authority

fosun pharmaceutical distribution jiangsu co. ltd - artemether + lumefantrine - oral solid ordinary soluble tablets - 40mg + 240mg